"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II st...

by Marchetti Paolo, Mancini Maria, De Galitiis Federica, Tudini Marianna, Baldi Paola, Cannita Katia, Santomaggio Alessandra, Bruera Gemma, Antonucci Adelmo, Ficorella Corrado, Ricevuto Enrico
Published 2010-10-01

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

by Clavarezza Matteo, Mustacchi Giorgio, Gardini Andrea, Del Mastro Lucia, De Matteis Andrea, Riccardi Ferdinando, Adamo Vincenzo, Aitini Enrico, Amoroso Domenico, Marchetti Paolo, Gori Stefania, Carrozza Francesco, Maiello Evaristo, Giotta Francesco, Dondi Davide, Venturini Marco
Published 2012-06-01